Suppliers / Delorbis Pharmaceuticals

Delorbis Pharmaceuticals

Cyprus 139 employees 2 duplicate records merged Updated 9 July 2026

Delorbis Pharmaceuticals is a finished-dose manufacturer based in Cyprus. It appears in 133 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with EDE (AE), EMA and DAV (Vietnam). Its GMP standing is certified by EMA.

0
active US DMFs
0
valid CEPs
2
registered plants
133
filings across 5 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Lefkosia, United Arab Emirates Not on file
Lefkosia, Cyprus Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
EDE (AE) 57 None
EMA 53 1
DAV (Vietnam) 14 None
EFDA (ET) 8 None
JFDA (JO) 1 None

Comparing suppliers?

Choose your molecules and target markets. Delorbis Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates